Drug industry, AARP fight over Medicare changes

Published



The biggest lobbyists for seniors and the pharmaceutical industry are fighting over an experiment to drastically reform how Medicare pays doctors.

AARP, the biggest senior lobbying group, said Monday it supports the Obama administration’s experiment to overhaul the payment model for Medicare Part B to ensure doctors prescribe cheaper drugs to patients. The proposal has received significant pushback from the pharmaceutical industry, cancer patient advocacy groups and many Republican lawmakers.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.